Juno.com is an bio-pharmaceutical corporation. In the beginning it collaborates with the Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center. and also Juno partnership with Seattle Kids Research Institute. Company started with the $120 million of investment to develop the immunotherapy drug for the treatment of Cancer disease.
Founded on: 2013
Nerve Center: Seattle, Washington, US
Founded by: Michael Jensen, Phil Greenberg, Stan Riddell, Revier Brentjens, Isabelle Riviere, Michael Sadelain.
CEO: Hans Bishop
Categories: Therapeutics, wellness, Health care and Biotechnology
Alternate Name: Juno Therapeutics Inc.
Employee Size: >500
Current status: Active
Funding Stats: M&A (Mergers & acquisitions)
Recent Funding Type: Series B
Juno Stock Price: NASDAQ:JUNO
Business Type: For Profit
It is a clinical company, it brings the international top 3 cancer centers. For chimeric antigen receptor Juno signed in an agreement with Opus Bio in 2014, this juno cell receptor targets the cell product candidates. In 2015 Juno company collaborated with MedImmune to take hand to investigate the cancer treatments.
Juno Pharma is established by the group of people and they have experience on pharmaceutical executives. They developed a wide range of generic products and pharmaceuticals and those are pending for approval.
Juno Therapeutics are two types:
- Redox Theropies
Here , Juno recruitment is having lots of vacancies for getting job as Juno employee. The job requirement will find in their official website on Juno therapeutics Careers page.
They have multiple candidates in developing the variety of cancers, The CAR T Cell product candidates applying for their TCR & CAR t cells technologies against cancer targets. The Juno Pipeline also having multiple requirement positions.
Juno Therapeutics Website: https://www.junotherapeutics.com
Juno Therapeutics Facebook: https://www.facebook.com/Juno-Therapeutics
Juno Therapeutics Twitter: https://twitter.com/JunoThera
Juno Therapeutics Email Address: [email protected]
Juno Therapeutics Helpline number: +1 206-696-0703